Disease-Modifying Technology
Experimental therapeutic devices designed to actively slow, halt, or reverse Parkinson's disease progression. Based on cutting-edge neuroscience research from MIT, Cleveland Clinic, and leading photobiomodulation labs worldwide.
Three devices, three disease mechanisms. Each targets a distinct pathway of Parkinson's pathology with published scientific evidence.
Synchronized light, sound, and vibration at 40Hz to transform microglia into phagocytic cleaners that consume toxic alpha-synuclein protein aggregates.
810nm near-infrared light rescues dying mitochondria in dopaminergic neurons by restoring cytochrome c oxidase activity, boosting cellular ATP production by 50-70%.
Monitors and guides pedaling cadence at 80-90 RPM — above voluntary pace — producing 35% motor improvement comparable to levodopa medication.
Each device targets a distinct mechanism of Parkinson's disease. Together, they mount a multi-front assault on neurodegeneration.
Clears toxic alpha-synuclein protein aggregates. Reduces neuroinflammation by converting microglia from pro-inflammatory to phagocytic state. Enhances cerebrospinal fluid clearance via glymphatic system activation.
Rescues dying mitochondria in dopaminergic neurons. Boosts neurotrophic factors (BDNF, GDNF) that protect remaining neurons. Reduces oxidative stress and restores cellular energy production.
Upregulates BDNF and GDNF through forced aerobic exercise. Improves mitochondrial biogenesis and function. Induces autophagy to clear damaged cellular components. Enhances dopamine signaling efficiency.
Combined approach: Protein clearance (Pulse) + mitochondrial rescue (Glow) + systemic neuroprotection (Cycle) addresses three of the four major pathological hallmarks of Parkinson's disease simultaneously.
All three therapeutic devices are orchestrated by a single Raspberry Pi 4, providing unified control, monitoring, and data analysis through a local web dashboard.
Medical-grade safety design with redundant protection at every level. No single point of failure can harm the user.
Physical emergency stop button, thermal fuse (auto-disconnect at 42°C), current-limiting resistors on all LED drivers, optically isolated control circuits.
Independent hardware watchdog timer. If the main application freezes or crashes, all therapeutic outputs are automatically disabled within 500ms.
State machine enforcing valid transitions only. Continuous thermal monitoring with graduated power reduction. Session time limits with mandatory cooldown periods.
Prominent epilepsy warnings before 40Hz sessions. Large, high-contrast emergency stop buttons. Clear session status with countdown timers. Accessibility-first design.
These devices are experimental research tools, not FDA-approved medical devices. They do not replace standard medical care. Always consult your neurologist before using any complementary therapeutic approach. The research cited on this page is promising but preliminary. Individual results may vary. Do not discontinue prescribed medications based on information presented here.
Open-source hardware and software. Published science. Everything you need to start building disease-modifying therapeutic devices.